Back to Executive Profile
Alpha

Alpha Profiles · Executive Profile

Gwenn M. Hansen, Ph.D.

Chief Scientific Officer at Nurix Therapeutics, Inc. (NASDAQ: NRIX)

https://registry.alpha.ac/people/gwenn-m-hansen-ph-d

GM

Generated 2026-10-22T22:23:44.941Z

Data as of 2026-10-22T22:23:44.595815+00:00

https://registry.alpha.ac/people/gwenn-m-hansen-ph-d